SCHEMBL2565072

SCHEMBL2565072

CN1Cc2ccccc2-n2c(nnc2C2CCC(c3ncc(F)cc3F)CC2)C1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 20/20 0.57
AVPR2 P30518 2/20 0.49
KCNH2 Q12809 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2539886 0.87 AVPR1A (0.60) AVPR1AAVPR2KCNH2
SCHEMBL2539890 0.87 AVPR1A (0.60) AVPR1AAVPR2KCNH2
SCHEMBL2559674 0.87 AVPR1A (0.64) AVPR1AAVPR2KCNH2
SCHEMBL2568096 0.82 AVPR1A (0.57) AVPR1AAVPR2KCNH2
SCHEMBL2573797 0.81 AVPR2 (0.44) AVPR1AAVPR2KCNH2
SCHEMBL16774879 0.80 AVPR1A (0.56) AVPR1AAVPR2KCNH2
SCHEMBL2547667 0.80 AVPR1A (0.56) AVPR1AAVPR2KCNH2
SCHEMBL2563310 0.78 AVPR1A (0.64) AVPR1AAVPR2KCNH2
SCHEMBL2542009 0.77 AVPR1A (0.67) AVPR1AAVPR2KCNH2
SCHEMBL2546578 0.77 AVPR1A (0.67) AVPR1AAVPR2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560975-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-27 EP claimed
WO-2011131596-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-27 WO claimed
EP-2560975-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-27 EP disclosed
WO-2011131596-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-27 WO disclosed